摘要
目的:研究尿激酶治疗急性心肌梗死的临床疗效。方法:选择急性心肌梗死患者152例,随机分为观察组77例和对照组75例,观察组给尿激酶溶栓治疗,而对照组给予常规治疗。用药后观察两组患者血管再通情况。结果:观察组总的血管再通率高于对照组;治疗4周后,对照组的病死率、急性肺水肿和心源性休克发生率高于观察组。结论:在治疗急性心肌梗死时,尿激酶静脉溶栓治疗可以提高心肌梗死患者冠状动脉血管的再通率,能够显著改善患者的预后。
Objective： Study the effect of urokinase treating acute myocardial infarction. Methods： 152 patients with acute myocardial infarction were randomly divided into two groups, study group 77 cases with urokinase fibrinolytic and controlled group 75 cases with common methods, observed recanalization. Results： Recanalization in study group was higher than in the control group. Conclusion： Urokinase could improve the recanalization of myocardial infarction patients, and could improve the prognosis of patients.
出处
《求医问药（下半月刊）》
2011年第4期61-61,共1页
Seek Medical and Ask The Medicine
